Treatment for fungal lung infections could be more efficient when medication is inhaled using nanoparticle technology, according to research from the University of Central Lancashire (UCLan).
May 21, 2021
0
10
(HealthDay)—The risk for severe postacute complications is low after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection not requiring hospitalization, according to a study published online May 10 in ...
May 17, 2021
0
2
A new study published in The Lancet Infectious Diseases journal has found that the risk of delayed acute complications after non-hospitalized SARS-CoV-2 infection is low, but persistent symptoms in this group could lead to ...
May 11, 2021
0
47
One in four people experience mild, short lived systemic side effects after receiving either the Pfizer or AstraZeneca vaccine, with headache, fatigue and tenderness the most common symptoms. Most side effects peaked within ...
Apr 27, 2021
0
40
Human T-cell lymphotropic virus type-1 (HTLV-1) is a retrovirus similar to human immunodeficiency virus (HIV) and has mostly been thought to be transmitted vertically (mother-to-child), or horizontally (sexually or parenterally ...
Apr 27, 2021
0
4
University of Queensland scientists have published the clinical trial data confirming their molecular clamp-stabilized vaccine technology was safe and potentially effective.
Apr 20, 2021
0
7
New data provide the first clinical evidence that drug-resistant mutations in the malaria parasite Plasmodium falciparum may be gaining a foothold in Africa. The study, conducted in Rwanda, is published in The Lancet Infectious ...
Apr 15, 2021
0
3
(HealthDay)—The B.1.1.7 variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is not associated with more severe illness or death but leads to higher viral load and is associated with increased R1, according ...
Apr 14, 2021
0
4
Two new studies, published in The Lancet Infectious Diseases and The Lancet Public Health, found no evidence that people with the B.1.1.7. variant experience worse symptoms or a heightened risk of developing long COVID compared ...
Apr 13, 2021
0
94
The median health care delay for patients with tuberculosis (TB) in the United States is 24 days, according to a study published online March 23 in The Lancet Infectious Diseases.
Mar 26, 2021
0
5
